SCHEMBL3673356

SCHEMBL3673356

Cc1cc(-c2cc3cnn(-c4ccc(F)cc4F)c3n(C)c2=O)c(C(N)=O)cc1F

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.59
LCK P06239 2/20 0.59
KIT P10721 2/20 0.59
KDR P35968 2/20 0.59
MAPKAPK2 P49137 2/20 0.59
CYP3A4 P08684 1/20 0.47
MAPK13 O15264 1/20 0.42
RAF1 P04049 1/20 0.42
PDGFRA P16234 1/20 0.42
MAPK12 P53778 1/20 0.42
KCNH2 Q12809 1/20 0.42
MAPK11 Q15759 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3671412 0.74 MAPK14 (1.00) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3632759 0.74 MAPK14 (0.69) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3671303 0.73 MAPK14 (0.70) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3673351 0.73 MAPK14 (0.63) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3636266 0.73 MAPK14 (0.82) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3667389 0.72 MAPK14 (0.79) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3634954 0.69 MAPK14 (1.00) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3673309 0.69 MAPK14 (0.58) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL1892898 0.68 MAPK14 (0.64) MAPK14LCKKITKDRMAPKAPK2
SCHEMBL3632376 0.67 MAPK14 (1.00) MAPK14LCKKITKDRMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152704-A1 PYRAZOLO-PYRIDINONE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE Amgen, Inc (US) 2010-02-17 EP disclosed
WO-2008137176-A1 PYRAZOLO-PYRIDINONE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE AMGEN INC. (US) 2008-11-13 WO disclosed